Edesa Biotech
EDSA
20 hedge funds and large institutions have $1.3M invested in Edesa Biotech in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
197% more capital inflows, than outflows
Capital inflows: $54.3K | Capital outflows: $18.3K
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.03% less ownership
Funds ownership: 9.77% → 9.73% (-0.03%)
9% less funds holding
Funds holding: 22 → 20 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$35.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.56K |
| 4 |
Morgan Stanley
New York
|
+$171 |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$9.38K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.84K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18 |
| 4 |
Wells Fargo
San Francisco,
California
|
-$12 |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
-$7 |
EDSA Hedge Fund Activity: Q3 2023 in Review
20 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2023, worth a combined $1.3M — down 20% from $1.63M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of EDSA and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was CM Management, adding an estimated $35.9K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $9.38K sold.
- 20 institutional investors held Edesa Biotech (EDSA) as of Q3 2023, down from 22 in Q2 2023.
- Funds reported $1.3M of Edesa Biotech stock for Q3 2023, down 20% quarter-over-quarter.
- 1 fund opened new Edesa Biotech positions in Q3 2023 and 3 closed out, a net change of -2 holders.
- The largest Edesa Biotech buyer in Q3 2023 was CM Management, an estimated $35.9K added.
- The largest Edesa Biotech seller in Q3 2023 was Two Sigma Investments, an estimated $9.38K sold.
Based on aggregated 13F filings for Q3 2023.